Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Remission in IDDM: prospective study of basal C-peptide and insulin dose in 268 consecutive patients

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Effect of Dapagliflozin in DAPA-HF According to Background Glucose-Lowering Therapy

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Influenza Vaccination Is Associated With Reduced Cardiovascular Mortality in Adults With Diabetes: A Nationwide Cohort Study

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Mannose-Binding Lectin and Risk of Cardiovascular Events and Mortality in Type 2 Diabetes: A Danish Cohort Study

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Impact of Glucose Level on Micro- and Macrovascular Disease in the General Population: A Mendelian Randomization Study

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Lactation Duration and Long-term Risk for Incident Type 2 Diabetes in Women With a History of Gestational Diabetes Mellitus

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

To elucidate beta-cell function, insulin requirement, and remission period in insulin-dependent diabetes mellitus (IDDM), a study was undertaken comprising 268 patients consecutively admitted to Steno Memorial Hospital with newly diagnosed IDDM. The patients were characterized by sex, age, and seasonal variation at onset of diabetes mellitus. During the first 36 mo of the disease, an evaluation was performed for basal C-peptide, HbA1c, and insulin dose per kilogram. Total remission was interpreted as complete discontinuation of insulin therapy for at least 1 wk while still metabolically well controlled, and partial remission was interpreted as an insulin need that was less than or equal to 50% of the insulin dose at discharge from the hospital. During the first 18 mo of the disease, 12.3% of the patients entered total remission (median 6 mo), and 18.3% of the patients entered partial remission (median 6 mo). Patients entering remission had significantly higher basal C-peptide levels than those who did not. Sex, age, and initial HbA1c levels did not influence the frequency of remission.

Original languageEnglish
JournalDiabetes Care
Volume10
Issue number2
Pages (from-to)164-9
Number of pages6
ISSN0149-5992
Publication statusPublished - 1 Mar 1987

    Research areas

  • Adolescent, Adult, Aged, C-Peptide, Child, Diabetes Mellitus, Type 1, Female, Hemoglobin A, Glycosylated, Humans, Insulin, Islets of Langerhans, Male, Middle Aged, Prospective Studies, Remission, Spontaneous, Journal Article

ID: 51521742